Alnylam Pharmaceuticals
ALNY
#571
Rank
C$56.67 B
Marketcap
C$427.31
Share price
-1.18%
Change (1 day)
17.75%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company